News Releases
SenesTech to Exhibit at PestWorld 2017 in Baltimore
SenesTech to exhibit their innovative technology for managing animal pest populations through fertility control at Booth # 1312
FLAGSTAFF, Ariz., Oct. 19, 2017 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a leader in technology for managing animal pest populations through fertility control, will exhibit ContraPest®, the EPA-approved fertility control product for controlling rat infestations, at PestWorld 2017 in Baltimore, MD on October 24-27.
"PestWorld offers a unique opportunity to present ContraPest to the pest management professional, or PMP, community," said Dr. Loretta Mayer, SenesTech's co-founder and chief executive officer. "On both scientific and practical levels, this is an ideal opportunity to explain ContraPest's role as the anchor of a successful integrated pest management program. In addition, we look forward to furthering our conversations with rodent management scientists and regulatory personnel."
"This is the place where deals are done in our industry," said Andy Altman, SenesTech's chief operating officer. "Whether it be pursuing or concluding preferred relationships with PMPs, or expanding our sales and distribution network by partnering with leading distributors in the industry, they are all at PestWorld, and we will be active with all of them."
The Revolutionary ContraPest Technology:
ContraPest's novel technology and approach targets the reproductive capabilities of both sexes, inducing egg loss in female rodents and impairing sperm development in males. Using a proprietary bait delivery method, ContraPest is dispensed in a highly palatable liquid formulation that promotes sustained consumption by rat communities. ContraPest is designed, formulated and dispensed to be safe for handlers and non-target species such as wildlife, livestock and pets, where the active ingredients break down rapidly, unlike rodenticides. In contrast, the historical approach to managing rodent pest populations, rodenticides, carries a high risk of environmental contamination and the poisoning of non-target animals, pets and children.
We believe our non-lethal approach, targeting reproduction, is more humane, and when used as directed, less harmful to the environment, and more effective in providing a sustainable solution to pest infestations than traditional lethal pest management methods.
Partnership Opportunities:
If you are a Pest Management Professional interested in offering your customers the novel ContraPest technology, please contact Jonathan Kersten at jonathan.kersten@senestech.com or 928-779-4143 extension 823 to set up a meeting at PestWorld.
Where to Find Us:
SenesTech will be showcasing ContraPest in Booth # 1312.
About Pest World:
PestWorld is the National Pest Management Associations (NPMA) annual event, gathering thousands of pest management professionals from across the globe to offer opportunities for information sharing, provide access to the latest products, services, and technologies in the 100,000 square foot exhibit hall, and generate critical thinking in world-class educational sessions. In attendance will be owners and managers of pest management companies, pest management technicians and sales representatives, product manufacturers and distributors, as well as industry researchers, educators and students. All general sessions, educational programs and the exhibit hall will be held at the Baltimore Convention Center located at 1 West Pratt Street, Baltimore, MD 21202. For more information, please visit: http://www.pestworld2017.org/.
About SenesTech
SenesTech has developed an innovative technology for managing animal pest populations through fertility control as opposed to a lethal approach.
The Company's first ContraPest's novel technology and approach targets the reproductive capabilities of both sexes, inducing egg loss in female rodents and impairing sperm development in males. Using a proprietary bait delivery method, ContraPest is dispensed in a highly palatable liquid formulation that promotes sustained consumption by rat communities. ContraPest is designed, formulated and dispensed to be safe for handlers and non-target species such as wildlife, livestock and pets, where the active ingredients break down rapidly, unlike rodenticides. In contrast, the historical approach to managing rodent pest populations, rodenticides, carries a high risk of environmental contamination and the poisoning of non-target animals, pets and children. ContraPest is a Restricted Use product.
We believe our non-lethal approach, targeting reproduction, is more humane, less harmful to the environment, and more effective in providing a sustainable solution to pest infestations than traditional lethal pest management methods. There is currently no other non-lethal fertility control product approved by the Food and Drug Administration (FDA), or the Environmental Protection Agency (EPA), for the management of rodent populations. We believe ContraPest® will establish a new paradigm in rodent control, resulting in improved performance in rodent control over rodenticides, without the negative environmental effects of rodenticides. For more information visit the SenesTech website at www.senestech.com.
Safe Harbor Statement
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors and other risks identified in our filings with the Securities and Exchange Commission. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management's assumptions and estimates as of such date. We do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.
CONTACT:
Investor: Robert Blum, Joe Dorame, Joe Diaz, Lytham Partners, LLC, 602-889-9700, senestech@lythampartners.com
Company: Tom Chesterman, Chief Financial Officer, SenesTech, Inc., 928-779-4143 extension 825
SOURCE SenesTech, Inc.
